General Information
- Hepatitis C Genotypes (AIDS InfoNet) and Spanish version
- Hepatitis C Genotypes and Quasispecies (U.S. Department of Veterans Affairs)
- HCV Genotype and Quasispecies (Hepatitis C Support Project)
- Are There Different Types of Hepatitis C? (Hepatitis Central)
- Genotypes Explained (Hepatitis Central)
- Hepatitis C Genotypes (Hepatitis Central)
Selected Recent Articles
- EASL issues new hepatitis C treatment recommendations for all genotypes. (September 2016, AIDSmap)
- AbbVie’s Combo Hepatitis C Treatment Performs Well with All Genotypes. (May 2016, Hepmag); related earlier coverage from Hepmag
- Ravidasvir plus sofosbuvir demonstrates high cure rate for people with hepatitis C genotype 4. (March 2016, AIDSmap)
- Pan-Genotypic Drugs. (January 2016, Hepmag)
- A Hep C Treatment for All Genotypes. (December 2015, Hepmag)
- Good Results for Sovaldi and Ravidasvir Treating Hep C Genotype 4. (November 2015, Hepmag)
- Daclatasvir and sofosbuvir with ribavirin cures 90% of people with genotype 3 hepatitis C. (November 2015, AIDSmap)
- Daclatasvir plus sofosbuvir works well for people with genotype 3 hepatitis C and advanced liver disease in real-world clinical practice. (November 2015, AIDSmap)
- High Genotype 2 and 3 Hep C Cure Rates for New AbbVie Combo. (November 2015, Hepmag)
- New AbbVie hepatitis C combination cures 93%-97% with genotype 3. (November 2015, AIDSmap)
- Sofosbuvir/ledipasvir plus vedroprevir shows 96% response rate for hard-to-treat genotype 1 hepatitis C patients. (November 2015, AIDSmap)
- Sofosbuvir/velpatasvir shows high cure rates for all HCV genotypes, works well for patients with liver decompensation. (November 2015, AIDSmap)
- Sofosbuvir and ravidasvir delivers high sustained response rates for genotype 4 hepatitis C patients. (November 2015, AIDSmap)
- Sofosbuvir/velpatasvir + GS-9857 for 8 weeks cures hepatitis C for most people with genotype 1 or 3. (November 2015, AIDSmap)
- New AbbVie hepatitis C pan-genotypic combination cures 97% – 100% in early study. (November 2015, AIDSmap)
- FDA OKs Harvoni for Hep C Genotypes 4, 5, 6, People with HIV. (November 2015, Hepmag)
- HCV Genotypes. (July 2015, Hepmag)
- Genotype 5. (July 2015, Hepmag)
- Genotype 3 [treatment]: An Unmet Need for Some. (July 2015, Hepmag)
- Hep C Treatment Is Sometimes Cost-Effective for Genotypes 2 and 3. (April 2015, Hepmag)
- Hepatitis C: The Global Spread of Genotype 1. (April 2015, Hepmag)
- Hepatitis C Genotype 3. (December 2014, Hepmag)
- Daclatasvir + sofosbuvir demonstrates good cure rate for genotype 3 hepatitis C. (November 2014, AIDSmap)
- ‘TRIO’ Regimen Cures 91% of Non-Cirrhotic Hep C Genotype 1. (November 2014, Hepmag)
- High Success For Harvoni Treating Coinfected Genotype 1. (November 2014, Hepmag)
- Sofosbuvir/ledipasvir cures nearly all genotype 1 HCV for people with HIV co-infection. (November 2014, AIDSmap)
- Alleged Misuse of Sovaldi for Hepatitis C Genotype 4 in Egypt. (November 2014, Hepmag)
- Higher Cirrhosis and Liver Cancer Risk for Hep C Genotype 3. (September 2014, Hepmag)
- Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4. (May 2014, AIDSmap)
- Gilead two-drug hep C combination cures 94% of genotype 1 patients in eight weeks. (December 2013, AIDSmap)
- Daclatasvir + asunaprevir cures 85% of genotype 1b hepatitis C patients in Japanese study. (November 2013, AIDSmap)
- Fixed-dose sofosbuvir/ledipasvir with or without ribavirin cures most genotype 1 hepatitis C patients, LONESTAR study shows. (November 2013, AIDSmap)
- Sofosbuvir + ribavirin produces sustained response in 76% of genotype 1 HIV/HCV co-infected people. (November 2013, AIDSmap)
- BMS interferon-free combination cures over 90% of genotype 1 hepatitis C in 12 weeks. (November 2013, AIDSmap)
- AbbVie’s two-drug, interferon-free combination cures genotype 1b hepatitis C infection in 95%. (November 2013, AIDSmap)
- Faldaprevir demonstrates good early response in genotype 1 HIV/HCV co-infection. (October 2013, AIDSmap)
- Simeprevir with interferon effective for HIV/HCV co-infected people with genotype 1 hepatitis C. (October 2013, AIDSmap)
- Hep C Genotype 3 Treatment Results Same in HIV Coinfection. (October 2013, Poz)
- Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people. (September 2013, AIDSmap)
- FDA approves first genotyping test for patients with hepatitis C virus. (June 2013, U.S. Food and Drug Administration)
